**Author details**

Laura Iliescu1,2\* and Letitia Toma1,2

1 Fundeni Clinical Institute, Bucharest, Romania

2 "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania

\*Address all correspondence to: laura\_ate@yahoo.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**135**

*Particularities of Hepatic Sarcoidosis*

[1] Coash M, Forouhar F, Wu CH, Wu GY. Granulomatous liver diseases: A review. Journal of the Formosan Medical Association. 2012;**111**(1):3-13. DOI: 10.1016/j.jfma.2011.11.023 ISSN

Histopathology of Liver. London: Oxford University Press; 1993.

[3] Sharma S. Granulomatous diseases of the liver. In: Zakim D, Boyer T, editors. Hepatology. 4th ed. Philadelphia, PA: Saunders, Elsevier Science; 2003.

Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: A 10 year single centre experience. Journal of Clinical Pathology. 2003;**56**:850-853

[5] Prasse A. The diagnosis, differential diagnosis, and treatment of sarcoidosis. Deutsches Ärzteblatt International. 2016;**113**(33-34):565-574. DOI: 10.3238/

[6] Rosen Y. Pathology of sarcoidosis. Seminars in Respiratory and Critical Care Medicine. 2007;**28**(1):36-52

Eckstein C. Etiology of sarcoidosis: Does infection play a role? Yale Journal of Biology and Medicine.

[8] Iliescu L, Herlea V, Toma L, Orban C. Association between chronic HCV hepatitis, membranoproliferative glomerulopathy and cutaneous

sarcoidosis. Journal of Gastrointestinal and Liver Diseases. 2015;**24**(1):8

[9] Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. New England Journal of Medicine. 2007;**357**(21):2153-2165

[7] Saidha S, Sotirchos ES,

2012;**85**(1):133-141

[2] Conn HO, Klatskin G.

[4] Gaya DR, Thorburn D,

**References**

0929-6646

pp. 293-311

pp. 1317-1330

arztebl.2016.0565

*DOI: http://dx.doi.org/10.5772/intechopen.90694*

[10] Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. Journal of Experimental Medicine.

[11] Loke WSJ, Herbert C, Thomas PS. Sarcoidosis: Immunopathogenesis and immunological markers. International

[12] Chen ESD, Moller DR. Sarcoidosis. In: Current Rheumatology Diagnosis

[13] Judson M. Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. Seminars in Respiratory

and Critical Care Medicine.

[14] Lewis J. Histopathology of granulomatous liver disease. Clinical Liver Disease. 2018;**11**(3):77-80

[15] Devaney K, Goodman Z,

Epstein M, et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. The American Journal of Surgical Pathology. 1993;**17**:1272-1280

[16] Andrade R, Lucena I, Fernandez M, et al. Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;**129**:512-521

[17] Lamps L. Hepatic granulomas. A review with emphasis on infectious cause. Archives of Pathology &

Laboratory Medicine. 2015;**139**:867-875

Hagspiel KD. Gastrointestinal and

sarcoidosis. The American Journal of Gastroenterology. 2008;**103**:3184-3192

[19] Tadros M, Forouhar F, Wu GY. Hepatic sarcoidosis. Journal of Clinical

[18] Ebert EC, Kierson M,

hepatic manifestations of

Journal of Chronic Diseases. 2013;**2013**:13, Article ID 928601

2006;**203**(2):359-370

and Treatment. 2004

2002;**23**(6):529-541

*Particularities of Hepatic Sarcoidosis DOI: http://dx.doi.org/10.5772/intechopen.90694*
